Fernández-Núñez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24 (4):e416-24.
doi:10.4317/medoral.22923
http://dx.doi.org/doi:10.4317/medoral.22923
___________________________________________________________________________________________________________________________________________________________________________________________
References
1. Lobbezoo F, Ahlberg J, Glaros AG, Kato T, Koyano K,
Lavigne GJ et al. Bruxism defined and graded:
An international consensus. J Oral Rehabil. 2013;40: 2-4. |
|
|
|
|
|
2. Manfredini D, Winocur E,
Guarda-Nardini L, Paesani D, Lobbezoo F. Epidemiology of bruxism in adults: A
systematic review of the literature. J Orofac Pain. 2013;27:99-110. |
|
|
|
|
|
3. Koyano K, Tsukiyama Y,
Ichiki R, Kuwata T. Assessment of bruxism in the clinic. J Oral Rehabil.
2008;35:495-508. |
|
|
|
|
|
4. Bader G, Kampe T, Tagdae T. Body movement during sleep in subjects with long-standing bruxing behavior. Int J Prosthodont. 2000;13:327-33. |
|
|
|
|
|
5. Manfredini D, Lobbezoo F.
Relationship between bruxism and temporomandibular disorders: A systematic
review of literature from 1998 to 2008. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 2010;109:e25-50. |
|
|
|
|
|
6. Pierce CJ, Chrisman K, Bennett ME et al. Stress, anticipatory stress, and psychologic measures re- lated to sleep bruxism. J Orofac Pain. 1995;9:51-6. |
|
|
|
|
|
7. Rugh JD, Barghi N, Drago
CJ. Experimental occlusal discrepancies and nocturnal bruxism. J Prosthet Dent.
1984;51:548-53. |
|
|
|
|
|
8. Lobbezoo F, Naeije M.
Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil.
2001;28:1085-91. |
|
|
|
|
|
9. Klasser GD, Rei N, Lavigne GJ. Sleep bruxism etiology: The evolution of a changing paradigm. J Can Dent Assoc. 2015;81:f2. |
|
|
|
|
|
10. Okeson JP. The effects
of hard and soft occlusal splints on nocturnal bruxism. J Am Dent Assoc.
1987;114:788-91. |
|
|
|
|
|
11. Saletu A, Parapatics S,
Saletu B, Anderer P, Prause W, Putz H y cols. On the pharmacotherapy of sleep
bruxism: Placebo-controlled polysomnographic and psychometric studies with
clonazepam. Neuropsychobiology.
2005;51:214-25. |
|
|
|
|
|
12.
Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum Neurotoxins: Biology,
Pharmacology, and Toxicology. Pharmacol Rev. 2017;69:200-35. |
|
|
|
|
|
13.
Urrútia G, Bonfill X. PRISMA declaration: A proposal to improve the
publication of systematic reviews and meta-analyses. Med Clin (Barc).
2010;135:507-11. |
|
|
|
|
|
14. SIGN 50: A guideline developer's handbook publication 50 [updated November 2015]. In: Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh. Available from http://www.sign.ac.uk. |
|
|
|
|
|
15. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: Higgins JPT, Green S, editors. The Cochrane collaboration. Available from www.cochrane-handbook.org. |
|
|
|
|
|
16.
Al-Wayli H. Treatment of chronic pain associated with nocturnal bruxism with botulinum
toxin. A prospective and randomized clinical study. J Clin Exp Dent.
2017;9:e112-17. |
|
|
|
|
|
17.
Zhang LD, Liu Q, Zou DR, Yu LF. Occlusal force characteristics of masseteric
muscles after intramuscular injection of botulinum toxin A (BTX - A) for
treatment of temporomandibular disorder. Br J Oral Maxillofac Surg.
2016;54:736-40. |
|
|
|
|
|
18.
Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin
injection on nocturnal bruxism: A randomized controlled trial. Am J Phys Med
Rehabil. 2010;89:16-23. |
|
|
|
|
|
19.
Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G.
Efficacy of botulinum toxin in treating myofascial pain in bruxers: A
controlled placebo pilot study. Cranio. 2008;26:126-35. |
|
|
|
|
|
20.
Blitzer A, Sulica L. Botulinum toxin: Basic science and clinical uses in
otolaryngology. Laryngoscope. 2001;111:218-26. |
||
|
|
|
21. Yin S, Stucker FJ, Nathan CO. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review). J La State Med Soc. 2001;153:92-97. |
|
|
|
|
|
22. Kato T, Thie NM, Huynh N, Miyawaki S, Lavigne GJ. Topical review: Sleep bruxism and the role of peripheral sensory influences. J Orofac Pain. 2003;17:191-213. |
|
|
|
|
|
23.
Lavigne GJ, Huynh N, Kato T, Okura K, Adachi K, Yao D y cols. Genesis of
sleep bruxism: Motor and autonomic-cardiac interactions. Arch Oral Biol.
2007;52:381-4. |
|
|
|
|
|
24.
Rao LB, Sangur R, Pradeep S. Application of Botulinum toxin type A: An
arsenal in dentistry. Indian J Dent Res. 2011;22:440-45. |
|
|
|
|
|
25. Fuster Torres MA, Berini Aytés L, Gay Escoda C. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12:511-7. |
|
|
|
|
|
26.
Alonso-Navarro H, Jiménez-Jiménez FJ, Plaza-Nieto JF, Pilo-De la Fuente B,
Navacerrada F, Arroyo-Solera M y cols. Treatment of severe bruxism with botulinum toxin type A. Rev Neurol. 2011;53:73-6. |
|
|
|
|
|
27.
Kim YK, Kim SG, Im JH, Yun PY. Clinical survey
of the patients with temporomandibular joint disorders, using Research
Diagnostic Criteria (Axis II) for TMD: Preliminary study. J
Craniomaxillofac Surg. 2012;40:366-72. |
|
|
|
|
|
28. Ihde SK, Konstantinovic
VS. The therapeutic use of botulinum toxin in cervical and maxillofacial
conditions: An evidence-based review. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 2007;104:e1-11. |
|
|
|
|
|
29. Tan EK, Jankovic J.
Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000;131:211-16. |
|
|
|
|
|
30.
Monroy PG, Da Fonseca MA. The use of
botulinum toxin-A in the treatment of severe bruxism in a patient with
autism: A case report. Spec
Care Dentist. 2006;26:37-39. |
|